| Autor: |
Sonpavde, G., Pond, G.R., Di Lorenzo, G., Buonerba, C., Rozzi, A., Lanzetta, G., Necchi, A., Giannatempo, P., Raggi, D., Matsumoto, K., Choueiri, T.K., Mullane, S., Niegisch, G., Albers, P., Lee, J.L., Kitamura, H., Kume, H., Bellmunt, J. |
| Zdroj: |
Clinical Genitourinary Cancer; 20240101, Issue: Preprints |
| Abstrakt: |
Prior platinum- versus non-platinum-based chemotherapy did not affect survival after controlling for major prognostic factors in patients receiving salvage systemic chemotherapy for advanced urothelial carcinoma. Exposure to prior platinum therapy should not be required for the inclusion of patients in trials of salvage systemic therapy. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
Full Text from ScienceDirect